Cargando…
Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
Neuroprotective drugs to protect the brain against cerebral ischemia and reperfusion (I/R) injury are urgently needed. Mammalian cell-produced recombinant human erythropoietin (rhuEPO(M)) has been demonstrated to have excellent neuroprotective functions in preclinical studies, but its neuroprotectiv...
Autores principales: | Kittur, Farooqahmed S., Hung, Chiu-Yueh, Li, P. Andy, Sane, David C., Xie, Jiahua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143832/ https://www.ncbi.nlm.nih.gov/pubmed/37111367 http://dx.doi.org/10.3390/ph16040610 |
Ejemplares similares
-
Plant-Produced Asialo-Erythropoietin Restores Pancreatic Beta-Cell Function by Suppressing Mammalian Sterile-20-like Kinase (MST1) and Caspase-3 Activation
por: Arthur, Elena, et al.
Publicado: (2017) -
Quantitative Proteomics Reveals the Beneficial Effects of Low Glucose on Neuronal Cell Survival in an in vitro Ischemic Penumbral Model
por: Li, Hua, et al.
Publicado: (2020) -
Rethinking the necessity of low glucose intervention for cerebral ischemia/reperfusion injury
por: Xie, Jiahua, et al.
Publicado: (2021) -
Recombinant asialoerythropoetin protects HL-1 cardiomyocytes from injury via suppression of Mst1 activation
por: Kittur, Farooqahmed S., et al.
Publicado: (2019) -
Regulation of one-carbon metabolism may open new avenues to slow down the initiation and progression of Huntington’s disease
por: Xie, Jiahua, et al.
Publicado: (2023)